Veraxa Biotech AG (VRXAW) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Veraxa Biotech AG (VRXAW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.8M, listed on NASDAQ, employing roughly 47 people, carrying a beta of 0.54 to the broader market. Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. Led by Christoph Antz, public since 2026-06-10.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for VRXAW as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →